Increased Fat Mass Compensates for Insulin Resistance in Abdominal Obesity and Type 2 Diabetes A Positron-Emitting Tomography Study

To evaluate the relative impact of abdominal obesity and newly diagnosed type 2 diabetes on insulin action in skeletal muscle and fat tissue, we studied 61 men with ( n = 31) or without ( n = 30) diabetes, subgrouped into abdominally obese or nonobese according to the waist circumference. Adipose tissue depots were quantified by magnetic resonance imaging, and regional glucose uptake was measured using 2-[18F]fluoro-2-deoxyglucose/positron emission tomography during euglycemic hyperinsulinemia. Across groups, glucose uptake per unit tissue weight was higher in visceral (20.5 ± 1.4 μmol · min−1 · kg−1) than in abdominal (9.8 ± 0.9 μmol min−1 · kg−1, P < 0.001) or femoral (12.3 ± 0.6 μmol · min−1 · kg−1, P < 0.001) subcutaneous tissue and ∼40% lower than in skeletal muscle (33.1 ± 2.5 μmol · min−1 · kg−1, P < 0.0001). Abdominal obesity was associated with a marked reduction in glucose uptake per unit tissue weight in all fat depots and in skeletal muscle ( P < 0.001 for all regions). Recent type 2 diabetes per se had little additional effect. In both intra-abdominal adipose ( r = −0.73, P < 0.0001) and skeletal muscle ( r = −0.53, P < 0.0001) tissue, glucose uptake was reciprocally related to intra-abdominal fat mass in a curvilinear fashion. When regional glucose uptake was multiplied by tissue mass, total glucose uptake per fat depot was similar irrespective of abdominal obesity or type 2 diabetes, and its contribution to whole-body glucose uptake increased by ∼40% in obese nondiabetic and nonobese diabetic men and was doubled in obese diabetic subjects. We conclude that 1 ) in abdominal obesity, insulin-stimulated glucose uptake rate is markedly reduced in skeletal muscle and in all fat depots; 2 ) in target tissues, this reduction is reciprocally (and nonlinearly) related to the amount of intra-abdominal fat; 3 ) mild, recent diabetes adds little insulin resistance to that caused by abdominal obesity; and 4 ) despite fat insulin resistance, an expanded fat mass (especially subcutaneous) provides a sink for glucose, resulting in a compensatory attenuation of insulin resistance at the whole-body level in men.